High Vista Strategies LLC has filed its 13F form on August 14, 2025 for Q2 2025 where it was disclosed a total value porftolio of $241 Million distributed in 146 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Invesco Db Commodity Index Tracking Fund with a value of $31.3M, Viridian Therapeutics, Inc.\De with a value of $6.77M, Ansys Inc with a value of $6.01M, Microsoft Corp with a value of $5.1M, and Immunovant, Inc. with a value of $5.03M.

Examining the 13F form we can see an increase of $10.2M in the current position value, from $230M to 241M.

High Vista Strategies LLC is based out at Boston, MA

Below you can find more details about High Vista Strategies LLC portfolio as well as his latest detailed transactions.

Portfolio value $241 Million
Healthcare: $87.7 Million
Technology: $55.2 Million
ETFs: $31.3 Million
Financial Services: $16.6 Million
Industrials: $15.9 Million
Consumer Cyclical: $14 Million
Energy: $5.25 Million
Utilities: $3.95 Million
Other: $8.17 Million

Stock Holdings Table Market Cap. of $200 Billions or more

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 146
  • Current Value $241 Million
  • Prior Value $230 Million
  • Filing
  • Period Q2 2025
  • Filing Date August 14, 2025
  • Form Type 13F-HR
  • Activity in Q2 2025
  • New Purchases 29 stocks
  • Additional Purchases 50 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 55 stocks
Track This Portfolio

Track High Vista Strategies LLC Portfolio

Follow High Vista Strategies LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of High Vista Strategies LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Vista Strategies LLC with notifications on news.